Method for amplifying lymphocyte by interleukin 15 receptor and interleukin 2 complex
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 浙江中赢控股集团有限公司
- Publication Date
- 2010-06-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of immunology, specifically refers to the use of interleukin 2, interleukin 15 receptor (IgG1 Fc)-interleukin 2 complex to expand natural killer cells (NK) and CD8 lymphocytes. technical background
[0002] Previous studies have shown that interleukin 2 and interleukin 15 are involved in the activation process of innate immunity and acquired adaptive immunity of NK cells, dendritic cells and CD8 cells. However, previous efforts to expand these cells with interleukin-15 or interleukin-2 in vitro and in vivo have been limited.
[0003] Interleukin 15 and interleukin 2 activate CD8 and NK cells by binding to specific receptors on the surface of CD8 and NK lymphocytes. Interleukin 2, interleukin 15 and interleukin 15 receptor are strongly expressed in activated dendritic cells and monocytes. Interleukin 2 and interleukin 15 can respectively bind to interleukin 15 receptors to form heterodimer complexes to activate CD8 a...